DEVELOPMENT OF AN ANTIVIRAL FOR YELLOW FEVER VIRUS INFECTION

Baruch S. Blumberg Institute, Doylestown PA

Investigators

Abstract

To support the advanced development of a promising candidate therapeutic for a virus covered under the Antiviral Program for Pandemics. The research and development activities to be supported will allow the candidate therapeutic product to progress through the product development pathway, and include preclinical and IND enabling development activities, chemistry optimization/development, GMP manufacturing, and clinical safety and efficacy assessment.